| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1365-2141.2000.02069.X |
| P698 | PubMed publication ID | 10929019 |
| P2093 | author name string | H Cohen | |
| M Greaves | |||
| I Mackie | |||
| S J MacHin | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| P304 | page(s) | 704-715 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Guidelines on the investigation and management of the antiphospholipid syndrome | |
| P478 | volume | 109 |
| Q41961544 | A 35-year-old man with dyspnea and hemoptysis |
| Q47924655 | A case of antiphospholipid syndrome presenting with pulmonary truncus and main pulmonary artery thrombosis |
| Q78311607 | A case study of familial anti-phospholipid syndrome |
| Q53591884 | A new Eu(3+)-labeled method for anticardiolipin antibody IgM. |
| Q37832035 | APS--controversies in diagnosis and management, critical overview of current guidelines. |
| Q60927212 | Acquired hemophilia A presenting as progressive intra-abdominal hemorrhage, muscle hemorrhage and hemothorax postpartum: A case report and literature review |
| Q28196376 | Acquired thrombophilias and pregnancy |
| Q35769744 | An audit of thrombophilia screens: results from the National Pathology Alliance benchmarking review |
| Q80509547 | Antiphospholipid antibodies in children with systemic lupus erythematosus: a prospective study in northern India |
| Q40337946 | Antiphospholipid antibodies proposed in the diagnosis of infective endocarditis |
| Q33371908 | Antiphospholipid syndrome: a series of surgical emergencies and the current evidence for its management |
| Q35172006 | Antiphospholipid syndrome: pathogenic mechanisms |
| Q34331685 | Antiphospholipid syndrome; its implication in cardiovascular diseases: a review |
| Q90480247 | Application of different lupus anticoagulant diagnostic algorithms to the same assay data leads to interpretive discrepancies in some samples |
| Q77231202 | Audit of laboratory investigation of antiphospholipid syndrome |
| Q33348045 | Beta‐2‐glycoprotein I antibodies in patients with thrombosis |
| Q44787262 | Central serous chorioretinopathy and antiphospholipid antibodies--results of a pilot study |
| Q36022335 | Combining Taipan snake venom time/Ecarin time screening with the mixing studies of conventional assays increases detection rates of lupus anticoagulants in orally anticoagulated patients |
| Q37473270 | Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome |
| Q21202147 | Consensus recommendations for the diagnosis and treatment of acquired hemophilia A |
| Q90312480 | Current Controversies in Lupus Anticoagulant Detection |
| Q33423959 | Current treatment of antiphospholipid syndrome: lights and shadows |
| Q35141108 | Deep venous thrombosis risk assessment, incidence, and prophylaxis in foot and ankle surgery |
| Q36577371 | Diagnosis of antiphospholipid syndrome |
| Q33939826 | Diagnosis of antiphospholipid syndrome in routine clinical practice |
| Q45191182 | Diagnosis of the antiphospholipid syndrome in anticoagulated patients |
| Q40539649 | Differences in the INR evaluation of two different thromboplastins in patients with positivity to lupus anticoagulant in ongoing oral anticoagulation |
| Q35547228 | Duration of Anticoagulant Therapy after Initial Idiopathic Venous Thromboembolism |
| Q61914569 | Effects of β2-glycoprotein I and monoclonal anticardiolipin antibodies in platelet interaction with subendothelium under flow conditions |
| Q64915469 | Etiology of Recurrent Pregnancy Loss in Saudi Females. |
| Q35709692 | Evaluating the conformation of recombinant domain I of β(2)-glycoprotein I and its interaction with human monoclonal antibodies |
| Q73429692 | Haemostatic changes in pregnancy |
| Q28394824 | Higher urinary bisphenol A concentration is associated with unexplained recurrent miscarriage risk: evidence from a case-control study in eastern China |
| Q40322522 | Hypercoagulability: interaction between inflammation and coagulation in familial Mediterranean fever |
| Q36254845 | Hypercoagulable states and stroke: a selective review. |
| Q35676030 | Indeterminate lupus anticoagulant results: Prevalence and clinical significance |
| Q47743642 | Innate immune response gene expression profiles characterize primary antiphospholipid syndrome. |
| Q36387401 | Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasis |
| Q37146064 | International recommendations on the diagnosis and treatment of patients with acquired hemophilia A |
| Q28175909 | Intracerebral hemorrhage in a patient with SLE and catastrophic antiphospholipid syndrome (CAPS): report of a case |
| Q35099172 | Laboratory diagnosis of the antiphospholipid syndrome |
| Q90480472 | Lupus anticoagulant mixing tests for multiple reagents are more sensitive if interpreted with a mixing test-specific cut-off than index of circulating anticoagulant |
| Q83351518 | North American and British guidelines for anti-thrombotic therapy: are we reaching consensus? |
| Q33747915 | Phospholipid-esterified eicosanoids are generated in agonist-activated human platelets and enhance tissue factor-dependent thrombin generation |
| Q36977996 | Prevalence and Resolution of Lupus Anticoagulant in Children |
| Q52957322 | Prevalence and clinical significance of anticardiolipin and anti-beta2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma. |
| Q34674429 | Primary anti-phospholipid antibody syndrome (APS): current concepts |
| Q74080326 | Prothrombin time inhibition detected with recombinant but not with conventional thromboplastins in two patients with high-titre IgM and moderate-titre IgA anticardiolipin antibodies |
| Q33345276 | Recent advances in the diagnosis of antiphospholipid syndrome |
| Q82752211 | Recurrent intestinal perforations as a presentation of antiphospholipid syndrome |
| Q38016378 | Recurrent miscarriage, antiphospholipid antibodies and the risk of thromboembolic disease |
| Q34573328 | Role of investigating thrombophilic disorders in young stroke. |
| Q44403824 | The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants |
| Q24798707 | The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin |
| Q37154882 | The enigmas of the lupus anticoagulant: mechanisms, diagnosis, and management |
| Q28186810 | The epidemiology of the antiphospholipid syndrome: who is at risk? |
| Q52935987 | The evaluation of clotting times in the laboratory detection of lupus anticoagulants. |
| Q34519511 | The lung in the antiphospholipid syndrome |
| Q34667153 | The prevalence of positive serum anticardiolipin antibodies and asymptomatic bacteriuria in women with recurrent abortions |
| Q28211977 | Thrombophilias in patients with ischemic stroke. Indication and calculated costs for evidence-based diagnostics and treatment |
| Q77589681 | [Hemorrhagic diathesis in a 67-year-old male with pain and limited mobility of the lower left limb] |
| Q77589666 | [Hughes syndrome and thrombosis: the debate goes on] |
Search more.